Medicine & Life Sciences
15-hydroxyprostaglandin dehydrogenase
13%
Acupuncture
29%
Adenocarcinoma
16%
Adjuvant Chemotherapy
9%
African Americans
9%
Anxiety
11%
Apoptosis
8%
Arachidonate 15-Lipoxygenase
23%
Arachidonate 5-Lipoxygenase
8%
Arachidonic Acid
14%
Breast
8%
Breast Neoplasms
56%
Cancer Pain
9%
Cancer Survivors
23%
Carboplatin
14%
Carcinogenesis
14%
Cardiac Glycosides
13%
Caregivers
11%
Celecoxib
14%
Chemoprevention
8%
Cisplatin
10%
Clinical Trials
12%
Colon
7%
Colonic Neoplasms
7%
Colorectal Neoplasms
25%
Communication
15%
Complementary Therapies
24%
Confidence Intervals
9%
Cutaneous T-Cell Lymphoma
8%
Cyclooxygenase 2
20%
Cyclooxygenase 2 Inhibitors
10%
Depression
20%
Dinoprostone
21%
Drug Therapy
36%
Education
7%
Eicosanoids
11%
Eicosapentaenoic Acid
9%
Emotional Adjustment
9%
Equipment and Supplies
10%
ErbB Receptors
9%
Fatigue
23%
gemcitabine
12%
Growth
12%
Head and Neck Neoplasms
12%
Hematology
7%
huachansu
12%
Immunotherapy
9%
Integrative Medicine
11%
Integrative Oncology
14%
Lipoxygenase
23%
Lung
10%
Lung Neoplasms
28%
Medical Oncology
14%
Meditation
12%
Melanoma
16%
Mindfulness
7%
Nausea
8%
Neoplasm Metastasis
13%
Neoplasms
100%
Nerium
15%
Non-Small Cell Lung Carcinoma
41%
oleandrin
26%
Oncologists
19%
Outpatients
7%
Ovarian Neoplasms
10%
Paclitaxel
9%
Pain
17%
Palliative Care
7%
Pancreatic Neoplasms
8%
PBI-05204
16%
Pemetrexed
7%
Peroxisome Proliferator-Activated Receptors
13%
Pharmaceutical Preparations
7%
Physicians
11%
Placebos
11%
Population
7%
Progression-Free Survival
7%
prostaglandin E3
16%
Prostate
8%
Prostatic Neoplasms
23%
Psychology
10%
Qigong
8%
Quality of Life
39%
Radiation
10%
Radiotherapy
23%
Randomized Controlled Trials
23%
Renal Cell Carcinoma
24%
Safety
8%
Sleep
13%
Small Cell Lung Carcinoma
7%
Social Adjustment
13%
Social Support
9%
Sulindac
7%
Survival
28%
Symptom Assessment
9%
Systematic Reviews
10%
Therapeutics
36%
Vulnerable Populations
9%
Xerostomia
12%
Yoga
21%